TSX-V:PCLO - TSX Venture Exchange - CA71716K1012 - Common Stock - Currency: CAD
TSX-V:PCLO (3/7/2025, 7:00:00 PM)
0.085
0 (0%)
The current stock price of PCLO.CA is 0.085 CAD. In the past month the price decreased by -5.56%. In the past year, price decreased by -52.78%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
BHC.CA | BAUSCH HEALTH COS INC | 1.87 | 3.77B | ||
CRON.CA | CRONOS GROUP INC | N/A | 1.08B | ||
TLRY.CA | TILRAY BRANDS INC | N/A | 928.28M | ||
DHT-UN.CA | DRI HEALTHCARE TRUST | 4.93 | 675.16M | ||
GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 546.47M | ||
DHT-U.CA | DRI HEALTHCARE TRUST | 3.62 | 495.53M | ||
ACB.CA | AURORA CANNABIS INC | N/A | 376.34M | ||
WEED.CA | CANOPY GROWTH CORP | N/A | 293.01M | ||
CPH.CA | CIPHER PHARMACEUTICALS INC | 12.54 | 288.91M | ||
HITI.CA | HIGH TIDE INC | N/A | 278.36M | ||
TSND.CA | TERRASCEND CORP | N/A | 249.63M | ||
NGEN.CA | NERVGEN PHARMA CORP | N/A | 198.02M |
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis extracts. Ubiquo is a knowledge management and medical consultation system that aims to create access to healthcare for Colombians.
PHARMACIELO LTD
82 Richmond Street East
TORONTO ONTARIO M5C 2V6 CA
CEO: David Attard
Employees: 49
Company Website: https://www.pharmacielo.com/
Investor Relations: http://www.pharmacielo.com/investors/
Phone: 14163158741.0
The current stock price of PCLO.CA is 0.085 CAD.
The exchange symbol of PHARMACIELO LTD is PCLO and it is listed on the TSX Venture Exchange exchange.
PCLO.CA stock is listed on the TSX Venture Exchange exchange.
PHARMACIELO LTD (PCLO.CA) has a market capitalization of 14.94M CAD. This makes PCLO.CA a Nano Cap stock.
PHARMACIELO LTD (PCLO.CA) currently has 49 employees.
PHARMACIELO LTD (PCLO.CA) has a resistance level at 0.09. Check the full technical report for a detailed analysis of PCLO.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PCLO.CA does not pay a dividend.
PHARMACIELO LTD (PCLO.CA) will report earnings on 2025-06-30.
PHARMACIELO LTD (PCLO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).
ChartMill assigns a technical rating of 1 / 10 to PCLO.CA. When comparing the yearly performance of all stocks, PCLO.CA is a bad performer in the overall market: 94.23% of all stocks are doing better.
Over the last trailing twelve months PCLO.CA reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS decreased by -1.95% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -71.19% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 80% to PCLO.CA. The Buy consensus is the average rating of analysts ratings from 6 analysts.